A tripeptide (NSK) inhibits Japanese encephalitis virus infection in vitro and in vivo

A tripeptide (NSK) inhibits Japanese encephalitis virus infection in vitro and in vivo Japanese encephalitis virus (JEV) is a major pathogen that can cause acute viral encephalitis in both humans and animals. Domain III of the viral envelope protein (EDIII) is involved in binding to host cell receptor(s) to facilitate virus entry. Our previous study showed that the loop3 peptide of EDIII possesses antiviral activity against JEV infection. In this paper, we demonstrate that three residues (NSK) in loop3 are responsible for the antiviral activity of loop3 peptide. In vitro experiments showed that the tripeptide NSK could inhibit JEV infection in both BHK-21 and Neuro-2A cells by inhibiting attachment of JEV to the cells, with IC 50 values of 8 μM and 6.5 μM, respectively. In vivo experiments showed that the tripeptide could increase the survival of mice challenged with JEV to 75 % when administrated intracerebrally. Therefore, this tripeptide may serve as the basis for the development of novel antiviral agents against Japanese encephalitis virus infection. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Virology Springer Journals

A tripeptide (NSK) inhibits Japanese encephalitis virus infection in vitro and in vivo

Loading next page...
 
/lp/springer_journal/a-tripeptide-nsk-inhibits-japanese-encephalitis-virus-infection-in-JDgFT7pEak
Publisher
Springer Vienna
Copyright
Copyright © 2014 by Springer-Verlag Wien
Subject
Biomedicine; Virology; Medical Microbiology; Infectious Diseases
ISSN
0304-8608
eISSN
1432-8798
D.O.I.
10.1007/s00705-013-1925-y
Publisher site
See Article on Publisher Site

Abstract

Japanese encephalitis virus (JEV) is a major pathogen that can cause acute viral encephalitis in both humans and animals. Domain III of the viral envelope protein (EDIII) is involved in binding to host cell receptor(s) to facilitate virus entry. Our previous study showed that the loop3 peptide of EDIII possesses antiviral activity against JEV infection. In this paper, we demonstrate that three residues (NSK) in loop3 are responsible for the antiviral activity of loop3 peptide. In vitro experiments showed that the tripeptide NSK could inhibit JEV infection in both BHK-21 and Neuro-2A cells by inhibiting attachment of JEV to the cells, with IC 50 values of 8 μM and 6.5 μM, respectively. In vivo experiments showed that the tripeptide could increase the survival of mice challenged with JEV to 75 % when administrated intracerebrally. Therefore, this tripeptide may serve as the basis for the development of novel antiviral agents against Japanese encephalitis virus infection.

Journal

Archives of VirologySpringer Journals

Published: May 1, 2014

References

  • The machinery for flavivirus fusion with host cell membranes
    Heinz, FX; Allison, SL
  • Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation
    Bressanelli, S; Stiasny, K; Allison, SL; Stura, EA; Duquerroy, S; Lescar, J; Heinz, FX; Rey, FA
  • Blocking the dengue virus 2 infections on BHK-21 cells with purified recombinant dengue virus 2 E protein expressed in Escherichia coli
    Chiu, MW; Yang, YL
  • Griffithsin inhibits Japanese encephalitis virus infection in vitro and in vivo
    Ishag, HZ; Li, C; Huang, L; Sun, MX; Wang, F; Ni, B; Malik, T; Chen, PY; Mao, X
  • Inhibition of Japanese encephalitis virus infection in vitro and in vivo by pokeweed antiviral protein
    Ishag, HZ; Li, C; Huang, L; Sun, MX; Ni, B; Guo, CX; Mao, X
  • Japanese encephalitis: immunocytochemical studies of viral antigen and inflammatory cells in fatal cases
    Johnson, RT; Burke, DS; Elwell, M; Leake, CJ; Nisalak, A; Hoke, CH; Lorsomrudee, W
  • Japanese encephalitis virus infection stimulates Src tyrosine kinase in neuron/glia
    Raung, SL; Chen, SY; Liao, SL; Chen, JH; Chen, CJ
  • Japanese encephalitis virus interacts with vimentin to facilitate its entry into porcine kidney cell line
    Das, S; Ravi, V; Desai, A
  • Pichia pastoris-expressed dengue virus type 2 envelope domain III elicits virus-neutralizing antibodies
    Batra, G; Raut, R; Dahiya, S; Kamran, N; Swaminathan, S; Khanna, N
  • Immunogenicity and protective efficacy of the E. coli-expressed domain III of Japanese encephalitis virus envelope protein in mice
    Alka, B; Alka, K; Malik, YP; Vrati, S

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off